Latest Industry Insights
Industry Insight
Using AI To Get Medicines to Patients Faster
To find out more about AI in pharma, Technology Networks spoke with Roger Palframan, head of US Research and digital for Early Solutions at UCB.
Industry Insight
Sourcing Chemistry From Inside Humans
In this interview, Dr. Jason Park, co-founder and CEO of Empress Therapeutics, tells us more about the Chemilogics platform and the benefits this approach to drug discovery can offer.
Industry Insight
Time Is of the Essence: Saliva-Based Test Could Detect Cancer Early
Technology Networks spoke to Nick Ainslie, co-founder of Ausel, to find out more about a saliva-based diagnostic designed to indicate the presence of cancer cells at the earliest stage of development without the need for invasive methods.
Industry Insight
The Pathology of Proteins: A Tangled Tale of Alzheimer's
Explore the current understanding from the scientific literature on how protein misfolding, mislocalization and malfunction can lead to Alzheimer's disease.
Industry Insight
The Ethical Implications of AI in Scientific Publishing
As the use of generative AI tools expands, and their potential in scientific research is better understood, there are ethical considerations to be made. Dr. Dror Kolodkin-Gal explores some of the issues and potential solutions.
Industry Insight
Cell Line Development Is Transforming the Future of Seafood Production
Explore how advances in food cultivation techniques make safer food alternatives possible while allowing marine wildlife to remain in the ocean to restore and replenish their populations.
Industry Insight
Increasing Widespread Accessibility of Molecular Testing for Oncology Research
Bio-Rad's Jeremiah McDole explores the benefits of bringing molecular testing in-house and how ddPCR technology can be applied in oncology workflows.
Industry Insight
Shaping the Future of Genomic Medicine
In this interview, James Brayer delves into some of the current obstacles hindering the widespread adoption of genomic medicine and highlights how nanopore-based sequencing can help to address them.
Industry Insight
Addressing One of the Most Common Dilemmas Faced by Oncologists
Technology Networks spoke to Dr. Ofer Sharon, CEO of OncoHost, to learn about the challenges in non-small cell lung cancer treatment and how proteomics-based analysis could enable personalized cancer treatments.
Industry Insight
Maximizing Cell Line Productivity and Efficiency
In this interview, Dr. Tabitha Bullock tells us about some of the key considerations in cell line development and how advances in technology are improving the efficiency and productivity of cell lines.
Advertisement
